University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT02411006
The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19104, United States
The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence. The investigators will send mailings to subjects once per month, and elicit responses via mail, phone, and web surveys.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ask people to predict their upcoming medication adherence
Ask people to commit to their upcoming medication adherence
Remind people to take their medicine
Keep patient predictions and commitment anonymous
Ask patients to report their predictions and commitments
Time frame: 6 months
frequency of refilling medication
Time frame: 6 months
Time frame: 6 months
University of Pennsylvania
Other
Prediction and Pre-commitment Mailings for Medication Adherence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial DetailsNCT05565716
Cardiovascular Diseases, Chronic Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07532564
Anemia, Anemia, Hemolytic
Baltimore, Maryland, United States
View Trial DetailsNCT04286555
Cardiovascular Diseases, Diabetes
Baltimore, Maryland, United States
View Trial Details